| Message: | Monoclonal antibodies (mAbs) are a rapidly growing class of human therapeutics representing an increasing number of drugs under development. Monoclonal antibodies have been used for treating cancer, autoimmune diseases, and infectious diseases in clinical practice. Antibody therapy directly targeted several immune checkpoints is demonstrating significant success in the past few years. Particularly, cancer therapy based on monoclonal antibodies against checkpoints of immune reaction is now regarded as a breakthrough method in oncological immunology. Nowadays, it is an urgent need to increase success rates of this immunotherapeutic approach and to extend it to more cancer types. Creative Biolabs, who always focuses on drug discovery and animal model, has successfully launched and established an exclusive Magic™ “humanized” animal model platform, which can provide the humanized PD-L1/CTLA-4 dual immune checkpoint knock-in mice to our clients all over the world. https://www.creative-biolabs.com/drug-discovery/therapeutics/magic-humanized-pd-l1-ctla-4-dual-immune-checkpoint-knock-in-mice.htm
|
my account
